From the Departments of Surgery (Wen, Dejesus, RS Radhakrishnan), University of Texas Medical Branch, Galveston, TX.
Pediatrics (GL Radhakrishnan, RS Radhakrishnan), University of Texas Medical Branch, Galveston, TX.
Received December 12, 2022; Accepted December 12, 2022.
CME questions for this article available at http://jacscme.facs.org
Disclosure Information: Authors have nothing to disclose. Timothy J Eberlein, Editor-in-Chief, has nothing to disclose. Ronald J Weigel, CME Editor, has nothing to disclose.
Support: Drs DeJesus and RS Radhakrishnan are supported by NIH grant [T32GM008256].
Disclaimer: PJ34 is not FDA approved for cardiac dysfunction following trauma or burn injury.
Presented at the Southern Surgical Association 134th Annual Meeting, Palm Beach, FL, December 2022
Supplemental digital content is available for this article.
Correspondence address: Ravi S Radhakrishnan, MD, MBA, FACS, 301 University Blvd, Galveston, TX 77550. email [email protected]